Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Linkesch

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Leukemia Research|June 27, 2000
Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot studyT Kühr, W Eisterer, U Apfelbeck, et al.
Bone Marrow Transplantation|September 28, 2010
Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-NetworkK Hohloch, P L Zinzani, W Linkesch, et al.
Acta Medica Austriaca|May 20, 2003
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphomaP Mikosch, H J Gallowitsch, W Zinke-Cerwenka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteersI Virgolini, A Kurtaran, M Leimer, et al.
Leukemia|December 13, 2003
High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidyH W Auner, A Zebisch, M G Schimek, et al.
Transplantation|November 15, 1995
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxisP Kalhs, S Brugger, I Schwarzinger, et al.
Oncology|January 1, 1985
Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseasesH Ludwig, A Cortelezzi, B G Van Camp, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assaysG Halwachs-Baumann, M Wilders-Truschnig, G Enzinger, et al.
European Journal of Haematology|September 25, 2002
Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamideH W Auner, C Tinchon, R I Brezinschek, et al.
British Journal of Haematology|July 1, 1996
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusionF Keil, P Kalhs, O A Haas, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Leukemia Research|June 27, 2000
Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot studyT Kühr, W Eisterer, U Apfelbeck, et al.
Bone Marrow Transplantation|September 28, 2010
Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-NetworkK Hohloch, P L Zinzani, W Linkesch, et al.
Acta Medica Austriaca|May 20, 2003
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphomaP Mikosch, H J Gallowitsch, W Zinke-Cerwenka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteersI Virgolini, A Kurtaran, M Leimer, et al.
Leukemia|December 13, 2003
High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidyH W Auner, A Zebisch, M G Schimek, et al.
Transplantation|November 15, 1995
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxisP Kalhs, S Brugger, I Schwarzinger, et al.
Oncology|January 1, 1985
Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseasesH Ludwig, A Cortelezzi, B G Van Camp, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assaysG Halwachs-Baumann, M Wilders-Truschnig, G Enzinger, et al.
European Journal of Haematology|September 25, 2002
Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamideH W Auner, C Tinchon, R I Brezinschek, et al.
British Journal of Haematology|July 1, 1996
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusionF Keil, P Kalhs, O A Haas, et al.
Pageof 15